Interestingly, the 2011 IASLC/ATS/ERS classification indicated that all the nonmucinous adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and lepidic adenocarcinoma were negative for TTF-1. This evidence concerns the gene TTF1 and adenocarcinoma in situ.